Health BehaviorNCT04281615
Examining Perceptions of the 24-Hr Movement Guidelines
A study testing Generic Message in people with Health Behavior and Self Efficacy, run by Dr. Amy Latimer-Cheung, PhD at 1 site in Canada.
Trial summary
The main objective of the proposed research is to experimentally test and inform the most effective brand attributes that is to be featured in the forthcoming Canadian 24-Hour Movement Guidelines for Adults. Specifically, there are two main objectives. Read more about this study
- Who is it for?
- Ages 18 to 64 yearsHealthy volunteers can take part
- Conditions the study is for
- Health Behavior, Self Efficacy
- What is being tested?
- Generic Message
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 247 participants
- Where
- 1 siteCanada
- Study dates
- 20 Jan 2020to 24 Feb 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- between 18-64 years
- Canadian
Who cannot join
- cannot read/write in English
- already self-reported meeting Guideline recommendations for all three behaviours (physical activity, sedentary behaviour, and sleep)
- self-reported medical condition and/or sleep condition that would prevent individual from meeting the Guideline recommendations
Trial locations and contacts
1 site in 1 country.
Canada1 site
School of Kinesiology and Health Studies
Kingston, Ontario, K7L3N6
About this study
Official title: Examining Perceptions and Brand Approaches for the Canadian 24-Hour Movement Guidelines for Adults
The main objective of the proposed research is to experimentally test and inform the most effective brand attributes that is to be featured in the forthcoming Canadian 24-Hour Movement Guidelines for Adults. Specifically, there are two main objectives. The first objective is to determine the most preferred tagline associated with the new Guidelines among a sample of Canadian adults. The second objective is to experimentally test if this new attribute fosters stronger perceptions of self-efficacy among an adult sample, when compared to previous threshold-based approaches.
- Conditions
- Health Behavior, Self Efficacy
- Being tested
- Generic Message
- Keywords
- Movement Behaviors, Physical Activity, Sedentary Behaviour, Sleep, Knowledge Translation
- Medical subject headings
- Health Behavior, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Generic MessageOther
Exposed to four sets of promotional materials hypothesized to increase perceptions of self-efficacy to meet Guidelines.
| Study group | Role | What they receive |
|---|---|---|
| Intervention (Generic Message) | Experimental | Receives promotional materials that feature a generic messaging approach. Receives: Other: Generic Message |
| Control (Threshold Message) | No intervention | Receives promotional materials that use traditional, threshold messages. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in participants self-efficacy to meet Guidelines measured using the Multi-Dimensional Self-efficacy for Exercise Scale (adapted, scale 0-10; 0=not at all confident, 10=extremely confident) following pre and post exposure to promotional materials.
Measured: 3 time points: measuring change from baseline, immediately after viewing message, 2-week follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Feb 2020
- Study start20 Jan 2020
- Primary completion24 Feb 2020
- Study completion24 Feb 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 247 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr. Amy Latimer-Cheung, PhD
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Dr. Amy Latimer-Cheung, PhD, Queen's University
- Investigators
- Amy E Latimer-Cheung, PhD, Principal investigator, Queen's University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04281615
- Sponsor's protocol ID
- 6027468
- Status last verified
- Sep 2021
- First submitted
- 18 Feb 2020
- Last updated
- 30 Sep 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining Perceptions and Brand Approaches for the Canadian 24-Hour Movement Guidelines for Adults
- ClinicalTrials.gov ID
- NCT04281615
- Acronym / sponsor ID
- 6027468
- Conditions
- Health Behavior, Self Efficacy
- Keywords
- Movement Behaviors, Physical Activity, Sedentary Behaviour, Sleep, Knowledge Translation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 247 participants (actual)
- Lead sponsor
- Dr. Amy Latimer-Cheung, PhDUniversity, hospital or other
- Study start
- 20 Jan 2020 (actual)
- Primary completion
- 24 Feb 2020 (actual)
- Study completion
- 24 Feb 2020 (actual)
- First posted
- 24 Feb 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective of the proposed research is to experimentally test and inform the most effective brand attributes that is to be featured in the forthcoming Canadian 24-Hour Movement Guidelines for Adults. Specifically, there are two main objectives. The first objective is to determine the most preferred tagline associated with the new Guidelines among a sample of Canadian adults. The second objective is to experimentally test if this new attribute fosters stronger perceptions of self-efficacy among an adult sample, when compared to previous threshold-based approaches.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention (Generic Message) | Experimental | Other: Generic MessageReceives promotional materials that feature a generic messaging approach. |
| Control (Threshold Message) | No intervention | –Receives promotional materials that use traditional, threshold messages. |
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- between 18-64 years
- Canadian
Key exclusion criteria (3 listed)
- cannot read/write in English
- already self-reported meeting Guideline recommendations for all three behaviours (physical activity, sedentary behaviour, and sleep)
- self-reported medical condition and/or sleep condition that would prevent individual from meeting the Guideline recommendations
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Generic MessageExposed to four sets of promotional materials hypothesized to increase perceptions of self-efficacy to meet Guidelines. | Other | Intervention (Generic Message) |
Primary outcome
Change in participants self-efficacy to meet Guidelines measured using the Multi-Dimensional Self-efficacy for Exercise Scale (adapted, scale 0-10; 0=not at all confident, 10=extremely confident) following pre and post exposure to promotional materials.
Time frame: 3 time points: measuring change from baseline, immediately after viewing message, 2-week follow up
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2021.
- Individual participant dataSharing planned: No
Related trials for Health Behavior
Not yet recruitingObservational study
A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...
Cardiometabolic Risk Factors, Mental Health
RecruitingObservational study
Pediatric Research in the Outpatient Setting CoHort
Parental Stress, Communication Disorder, Childhood
Active, not recruiting
Health enSuite Caregivers: an App-based Treatment for Distressed Caregivers of Persons With Moderate Dementia
Caregiver Burnout
Active, not recruiting
AI Mental Health Tool vs. Psychoeducation Control
Depressive Disorder, Depressive Symptoms
Active, not recruitingObservational study
Gulf Long-Term Follow-Up Study
Cardiovascular Disease, Hematologic Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amy E Latimer-Cheung, PhD principal investigator
Queen's University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Generic Message in people with Health Behavior and Self Efficacy, run by Dr. Amy Latimer-Cheung, PhD at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in participants self-efficacy to meet Guidelines measured using the Multi-Dimensional Self-efficacy for Exercise Scale (adapted, scale 0-10; 0=not at all confident, 10=extremely confident) following pre and post exposure to promotional materials. (time frame: 3 time points: measuring change from baseline, immediately after viewing message, 2-week follow up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2021.